Drugs acting on serotonin receptors for the treatment of functional GI disorders (Q36478089)

14 August 2017

1 reference

title

Drugs acting on serotonin receptors for the treatment of functional GI disorders (English)

1 reference

14 August 2017

Marcello Tonini

1

1 reference

14 August 2017

Fabio Pace

series ordinal

2

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

24

1 reference

14 August 2017

issue

1-2

1 reference

14 August 2017

page(s)

59-69

1 reference

Management of the irritable bowel syndrome

14 August 2017

cites work

1 reference

Basic pathophysiologic mechanisms in irritable bowel syndrome

21 January 2018

1 reference

Irritable bowel syndrome: a little understood organic bowel disease?

21 January 2018

1 reference

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

New developments in the treatment of functional dyspepsia

21 January 2018

1 reference

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

Visceral hypersensitivity

21 January 2018

1 reference

Irritable bowel syndrome: new agents targeting serotonin receptor subtypes

21 January 2018

1 reference

Serotoninergic neuroenteric modulators

21 January 2018

1 reference

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine

21 January 2018

1 reference

5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle

21 January 2018

1 reference

5-HT4 receptors located on cholinergic nerves in human colon circular muscle

21 January 2018

1 reference

Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics

21 January 2018

1 reference

Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management

21 January 2018

1 reference

New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline

21 January 2018

1 reference

Effect of renzapride on transit in constipation-predominant irritable bowel syndrome

21 January 2018

1 reference

The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers

21 January 2018

1 reference

Prucalopride, a systemic enterokinetic, for the treatment of constipation

21 January 2018

1 reference

Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation

21 January 2018

1 reference

Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

Recent advances in the pharmacology of gastrointestinal prokinetics

21 January 2018

1 reference

The Serotonin 5-HT4 Receptor. 2. Structure-Activity Studies of the Indole Carbazimidamide Class of Agonists

21 January 2018

1 reference

Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women

21 January 2018

1 reference

Review article: tegaserod

21 January 2018

1 reference

Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity

21 January 2018

1 reference

Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine

21 January 2018

1 reference

Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro

21 January 2018

1 reference

The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients

21 January 2018

1 reference

Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron

21 January 2018

1 reference

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

21 January 2018

1 reference

Towards a reduction of rectal pain?

21 January 2018

1 reference

A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia

21 January 2018

1 reference

Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans

21 January 2018

1 reference

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome

21 January 2018

1 reference

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

21 January 2018

1 reference

Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation

21 January 2018

1 reference

Irritable bowel syndrome: a syndrome in evolution

21 January 2018

1 reference

Systematic review: the epidemiology of ischaemic colitis

21 January 2018

1 reference

Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea

21 January 2018

1 reference

Review article: cardiac adverse effects of gastrointestinal prokinetics

21 January 2018

1 reference

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

21 January 2018

1 reference

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study

21 January 2018

1 reference

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

21 January 2018

1 reference

5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract

21 January 2018

1 reference

Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis

21 January 2018

1 reference

Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial

21 January 2018

1 reference

Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia

21 January 2018

1 reference

Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study

21 January 2018

1 reference

Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man

21 January 2018

1 reference

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

21 January 2018

1 reference

The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study

21 January 2018

1 reference

Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans

21 January 2018

1 reference

Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000090309

1 reference

14 August 2017

1 reference